Главная
Study mode:
on
1
Intro
2
Genetic studies
3
What are genetics
4
Affymetrix chips
5
Polygen
6
Risk variance
7
Risk factors
8
New biology
9
Complex disease
10
Source of study
11
Noncoding regions
12
G1 studies
13
Computational approaches
14
Pathway analysis
15
Other studies
16
MicroRNAs
17
Mendelian evangelization
18
MRAS
19
Cholesterol
20
LDL
21
Functional genomics
22
Target discovery
23
Reducing triglycerides
24
Homozygous FH
25
Antisense
26
Security randomization
27
Genetics and coronary disease
28
Genetic risk score
29
Risk alleles
30
Polygenic risk
31
Thank you
32
Question
Description:
Learn about coronary artery disease through a comprehensive research conference presentation that explores genetic studies, risk factors, and drug development. Delve into advanced topics including Affymetrix chips, polygenic risk variance, noncoding regions, and computational approaches in cardiovascular genetics. Explore the relationship between genetics and coronary disease, examining microRNAs, Mendelian evangelization, cholesterol, LDL, and functional genomics. Discover cutting-edge developments in target discovery, antisense technology, and security randomization while understanding how genetic risk scores and risk alleles contribute to disease management. Presented by Dr. Ruth McPherson, Director of the Ruddy Canadian Cardiovascular Genetics Centre and Professor at the University of Ottawa, this hour-long talk provides valuable insights into the intersection of genetics and cardiovascular medicine.

Coronary Artery Disease - From Genetics to Drug Development

University of Ottawa Heart Institute
Add to list
0:00 / 0:00